UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
  
 FORM 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
 
 For the month of August 2022
 
Commission File Number:  001-39034
 
BELLUS HEALTH INC.
 

(Name of registrant)


275 Armand-Frappier Blvd.
 Laval, Québec
 H7V 4A7
Canada

(Address of principal executive offices)

 
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
 
 
☐    Form 20-F
☒   Form 40-F 
 
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ☐
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ☐
  

 

SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 

 
BELLUS Health Inc.
 
 
 
 
 
 
Date: August 10, 2022
By:
/s/ Ramzi Benamar
 
 
Name:  Ramzi Benamar   
 
 
Title:    Chief Financial Officer
 
 
 
 

 Form 6-K Exhibit Index
 
Exhibit
Number
 
Document Description
 
 
 
 


BELLUS Health (NASDAQ:BLU)
Historical Stock Chart
From Nov 2022 to Dec 2022 Click Here for more BELLUS Health Charts.
BELLUS Health (NASDAQ:BLU)
Historical Stock Chart
From Dec 2021 to Dec 2022 Click Here for more BELLUS Health Charts.